ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1760 • ACR Convergence 2023

    Methotrexate Augments the Release of Granulocyte-macrophage Colony-stimulating Factor from Activated Rheumatoid Arthritis Fibroblast-like Synoviocytes – Possible Consequences for Persistence of Joint Inflammation

    Beatrice Bergström1, Tilia Selldén1, Miriam Bollmann2, Mattias N.D Svensson1 and Anna-Karin Hultgård Ekwall3, 1University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 3University of Gothenburg, Kullavik, Sweden

    Background/Purpose: Activated fibroblast-like synoviocytes (FLS) are important mediators of synovitis and structural damage in rheumatoid arthritis (RA)[1]. Granulocyte-macrophage colony-stimulating factor (GM-CSF, encoded by the CSF2…
  • Abstract Number: 1744 • ACR Convergence 2023

    Histological and Molecular Comparison in the Synovial Tissue of Patients with Active Rheumatoid Arthritis to Remission

    Selina Ohl1, Klaus Frommer1, Markus Rickert2, Stefan Rehart3, Ulf Müller-Ladner1 and Elena Neumann1, 1Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, 2Dept. of Orthopaedics and Orthopaedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, 3Dept. of Orthopaedics and Trauma Surgery, Agaplesion Markus Hospital Frankfurt, Frankfurt, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease which leads to local and systemic manifestations. Subsequently, the inflamed synovium drives the destruction of…
  • Abstract Number: 1755 • ACR Convergence 2023

    Unique Pattern of Cadherin 6 Localization in Fibroblast-Like Synoviocytes

    Camilla R. L. Machado1, David Boyle1, Narayanan B. Perumal2, Robert J. Benschop3 and Gary Firestein1, 1University of California San Diego, San Diego, CA, 2Eli Lilly and Company, San Diego, CA, 3Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: The synovial lining of rheumatoid arthritis (RA) is formed by a network of fibroblast-like synoviocytes (FLS). Cadherins are type I transmembrane proteins and participate…
  • Abstract Number: 1877 • ACR Convergence 2023

    Diagnostic Yield of 18F-FDG PET-CT for Large Vessel Involvement in Patients with Suspected Giant Cell Arteritis and Negative Temporal Artery Biopsy

    Javier Narvaez1, Paula V. Estrada-Alarcón2, Paola Vidal-Montal3, Iván Sánchez-Rodriguez4, Aida Sabate-Llobera4, Montserrat Cortes-Romera4 and Joan Miquel Nolla5, 1Hospital Universitario de Bellvitge, Barcelona, Spain, 2Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 3Department of Rheumatology. Hospital Universitario de Bellvitge, Barcelona, Spain, 4Department of Nuclear Medicine – PET IDI. Hospital Universitario de Bellvitge, Barcelona, Spain, 5Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain

    Background/Purpose: Every effort should be made to confirm a suspected diagnosis of giant cell arteritis (GCA). According to the 2018 update of the EULAR recommendations…
  • Abstract Number: 1759 • ACR Convergence 2023

    Runx1 Is a Key Transcription Factor That Drives Synovial Fibroblast Pathogenicity in Rheumatoid Arthritis

    Christopher Mahony1, Samuel Kemble2, Paulynn Chin1, Cesar Prada3, Annie Hackland1, Patricia Reis-Nisa1, Lucy-Jayne Marsh1, Peter Keane1, Constanze Bonifer1, Christopher Buckley4, Stevephen Sansom5, Mark Coles4 and Adam Croft1, 1University of Birmingham, Birmingham, United Kingdom, 2University Birmingham, Rugeley, United Kingdom, 3The Kennedy Institute, Oxford, United Kingdom, 4University of Oxford, Oxford, United Kingdom, 5Kennedy Institute of Rheumatology, Oxford, United Kingdom

    Background/Purpose: Fibroblasts are key effector cells in rheumatoid arthritis (RA) underpinning joint inflammation and damage. Synovial tissue fibroblasts are heterogenous and acquire pathogenic cell states…
  • Abstract Number: 1880 • ACR Convergence 2023

    Performance of Machine Learning Algorithms in Discriminating Spondyloarthritis Features on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis

    Sun Jae Moon1, Seulkee Lee1, Seonyoung Kang1, Hyungjin Kim1, Jaejoon Lee1, Jinseok kim2, Eun-Mi Koh3, Jinseub Hwang4 and Hoon-Suk Cha1, 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, South Korea, 3Health Insurance Review and Assessment Service, Seoul, South Korea, 4Department of Data Science, Daegu University, Gyeongsan, South Korea

    Background/Purpose: The diagnostic role of Magnetic Resonance Imaging (MRI) for axial spondyloarthritis(axSpA) has grown since introducing the ASAS criteria for axSpA. Recent advances in machine…
  • Abstract Number: 1762 • ACR Convergence 2023

    Single-cell RNA Sequencing Analysis and Immune Profiling of Antigen-specific T Cells in Patients with Rheumatoid Arthritis and Healthy Controls

    JING SONG1, Cliff Rims1, Matthew Dufort1, Peter Linsley1, Eddie James2 and Jane Buckner2, 1Benaroya Research Institute, Seattle, WA, 2Benaroya Research Institute at Virginia Mason, Seattle, WA

    Background/Purpose: Single-cell analysis has emerged as a powerful tool for investigating the transcriptomics and T-cell receptor (TCR) diversity in patients with rheumatoid arthritis (RA). However,…
  • Abstract Number: 1734 • ACR Convergence 2023

    Serum PDGF-BB Levels Correlate with Lung Fibrosis in Mice Injected with Malondialdehyde-Acetaldehyde and/or Citrulline Modified Vimentin

    Nozima Aripova1, Michael Duryee1, Carlos Hunter1, Amy Nelson1, Breanna Butler1, Jill Poole1, Bryant England1, Geoffrey Thiele1 and Ted R Mikuls2, 1University of Nebraska Medical Center, Omaha, NE, 2Division of Rheumatology and Immunology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Pulmonary manifestations of rheumatoid arthritis (RA), such as interstitial lung disease (RA-ILD), are a major contributor to morbidity and mortality. The mechanism of pulmonary…
  • Abstract Number: 1881 • ACR Convergence 2023

    Deep Learning Approaches to Rheumatoid Arthritis Severity Prognosis

    Zhong-Yuan Lai1, Aditya Varna Iyer2, Isaac Zachary To1, Ivano Lodato1, Simran Hiranandani1, Tommy LAM3, Ho So4 and Lai-Shan Tam5, 1Allos AI, London, United Kingdom, 2Allos AI, University of Oxford, Oxford, United Kingdom, 3Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong, 4Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 5The Chinese University of Hong Kong, New Territories, China

    Background/Purpose: Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis affecting a large sector of the global population. The disease is associated with…
  • Abstract Number: 1747 • ACR Convergence 2023

    A Newly Described Cytokine interleukin-40 Is Increased in the Serum of Individuals At-risk of Rheumatoid Arthritis and Induces an Inflammatory Response in Mononuclear Cells

    Adela Navratilova1, Klára Prajzlerová2, Nora Růžičková3, Karel Pavelka4, Jiri Vencovsky5, Ladislav Senolt6, Maria Filkova3 and Lucie Andrés Cerezo3, 1Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Hlavní město Praha, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 4Institut of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Praha, Czech Republic, 5Institute of Rheumatology, Prague, Czech Republic, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 6Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Praha, Czech Republic

    Background/Purpose: Interleukin-40 (IL-40) is a newly described cytokine related to malignancies and immunity function. We have previously shown that IL-40 is up-regulated in early stages…
  • Abstract Number: 1738 • ACR Convergence 2023

    Identification of Homeostatic and Inflammatory Synovial Fibroblast Signatures in Synovial Tissue Biopsies of Healthy Controls and Patients with Rheumatoid Arthritis

    Brianne Barker1, Órla Tynan2, Conor Smith3, Dumitru Anton4, Carl Orr5, Mary Canavan6, Douglas Veale7 and Ursula Fearon8, 1Molecular Rheumatology, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Rheumatic and Arthritic Diseases, St Vincent's University Hospital, University College Dublin, Dublin, Ireland, 2Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 3Translational Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland, 4Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 5EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 6Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland, 7St.Vincent's University Hosp, Dublin, Ireland, 8Trinity College Dublin, Dublin, Ireland

    Background/Purpose: Recent literature has identified different synovial fibroblast (FLS) populations within RA synovium with distinct inflammatory profiles. Despite current advances in classifying heterogeneity of FLS…
  • Abstract Number: 1743 • ACR Convergence 2023

    Individuals At-risk for and with Rheumatoid Arthritis Have Elevated Fecal Concentrations of Arthritogenic Subdoligranulum didolesgii Correlating with CCP3 Antibodies

    Lyndsey Cole1, Sucai Liu2, Brendan Allen2, Marie Feser3, Kristen Demoruelle3, kevin Deane3, Michael Holer3 and kristine Kuhn2, 1University of Colorado School of Medicine, Centennial, CO, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Our prior investigation identified a specific strain of Subdoligranulum didolesgii, S. dido7, to which dual IgA/IgG family plasmablast-derived monoclonal autoantibodies from individuals at-risk for…
  • Abstract Number: 1753 • ACR Convergence 2023

    Acylcarnitine Enrichment Is a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint

    Georgios Vasileiadis1, Anna-Karin Hultgård Ekwall2, Reshmi Sureshkumar1, Monica Guma3, Anna Rudin4, Yuan Zhang1 and Cristina Maglio1, 1Institute of Medicine, University of Gothenburg, Gothenburg, Sweden, 2Department of Rheumatology and Inflammation research, Sahlgrenska Academy, University of Gothenburg, Kullavik, Sweden, 3San Diego VA Healthcare Service, La Jolla, CA, 4Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Several metabolic pathways have been implicated in rheumatoid arthritis fibroblast-like synoviocytes (RA FLS) aggressive phenotype1,2. Here, we aimed to analyse the full spectrum of…
  • Abstract Number: 1359 • ACR Convergence 2023

    Association of Menstrual Cycles and Disease Flare Activity in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Lucy Masto1, Amaya Smole1, Caroline Siegel1, Sarah Lieber2, Sanjana Adurty3, Jonah Levine1, Bessie Stamm1, Lisa Mandl2, Michael Lockshin2, Lisa Sammaritano2 and Medha Barbhaiya2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 3Weill Cornell Medical College, New York, NY

    Background/Purpose: Whether the timing of menstruation impacts disease activity or severity among women with SLE or RA is poorly understood. We evaluated systemic rheumatic disease…
  • Abstract Number: 1371 • ACR Convergence 2023

    Are Ultrasound Salivary Parenchymal Abnormalities More Severe in Primary Sjögren Patients with a Higher Disease Duration ? A Cross-sectional International Study

    Alice TISON1, sandrine jousse joulin2, Maëlys Consigny3, Philipp Moog4, Benedikt Hofauer5, Eric Hachulla6, Christophe Lamotte7, JACQUES MOREL8, Gael Mouterde9, Vera Milic10, Hendrika Bootsma11, Alja Stel12, Benjamin A Fisher13, Mark Maybury14, Alan Baer15, Dana Direnzo16, Hae-Rim Kim17, Hong Ki Min18, Shin-Seok Lee19, Sung-Eun Choi19, Guillermo CARVAJAL ALEGRIA20, Sylvie Boisramé21, Dewi Guellec22, Divi Cornec23, Malin Jonsson24, Daniel Hammenfors25, Alain SARAUX26 and Valerie Devauchelle27, 1CHU de la Cavale Blanche, Brest, France, 2Rheumatology, CHU Brest, Brest, France, 3Biostatistics, CHU Brest, Brest, France, 4Rheumatology, CHU Munich, Munich, Germany, 5Otolaryngology, CHU Munich, Munich, Germany, 6University of Lille, Lille, France, 7Internal Medicine and Clinical Immunology, CHU Lille, Lille, France, 8Protocole thérapeutique immuno-rhumatologie, Montpellier, France, 9CHU Lapeyronie, Montpellier, France, 10Rheumatology, University of Belgrade, Medical School, Belgrade, Serbia, 11Department of Rheumatology, University Medical Centre Groningen, Groningen, Netherlands, 12Rheumatology and clinical immunology, University Medical Center Groningen, Groningen, Netherlands, 13University of Birmingham, Birmingham, United Kingdom, 14Rheumatology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 15Johns Hopkins University School of Medicine, Baltimore, MD, 16University of Pennsylvania, Bala Cynwyd, PA, 17Rheumatology, Konkuk University Medical Center, Seoul, South Korea, 18Konkuk University School of Medicine, Seoul, South Korea, 19Chonnam National University Medical School & Hospital, Gwangju, South Korea, 20CHRU de Tours, Tours, France, 21Ondontology, CHU Brest, France, Brest, France, 22CHU de Brest, Brest, France, 23University of Brest, Brest, France, 24Clinical dentistry, University of Bergen, Bergen, Norway, Bergen, Norway, 25Rheumatology, Haukeland University Hospital, Bergen, Norway, 26CHU Brest, Brest, France, 27UBO, Brest, France

    Background/Purpose: Salivary gland ultrasonography (SGUS) is commonly used in primary Sjögren Disease (pSD) as a diagnostic tool. It could also be used to monitor disease…
  • « Previous Page
  • 1
  • …
  • 419
  • 420
  • 421
  • 422
  • 423
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology